While the role of the CTLH E3 ligase complex has not been investigated in AD, previous proteomics-based interactome studies of AD brain tissue have consistently identified these same CTLH E3 ligase subunits as highly significant tau interactors [17, 22, 27, 52]. The gene discussed is MAPT; the disease is Alzheimer disease.